Short Interest in Utah Medical Products, Inc. (NASDAQ:UTMD) Rises By 16.6%

Utah Medical Products, Inc. (NASDAQ:UTMD) was the target of a large increase in short interest in the month of November. As of November 30th, there was short interest totalling 64,500 shares, an increase of 16.6% from the November 15th total of 55,300 shares. Based on an average daily volume of 22,200 shares, the days-to-cover ratio is presently 2.9 days. Currently, 2.0% of the company’s stock are short sold.

Utah Medical Products Stock Up 0.5 %

Utah Medical Products stock traded up $0.34 during midday trading on Monday, reaching $62.95. The stock had a trading volume of 11,527 shares, compared to its average volume of 21,704. Utah Medical Products has a 12 month low of $62.62 and a 12 month high of $87.00. The firm’s 50-day moving average price is $65.24 and its 200 day moving average price is $66.78. The firm has a market capitalization of $213.40 million, a PE ratio of 14.73 and a beta of 0.08.

Utah Medical Products Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, January 3rd. Investors of record on Monday, December 16th will be paid a $0.305 dividend. The ex-dividend date of this dividend is Monday, December 16th. This is a boost from Utah Medical Products’s previous quarterly dividend of $0.30. This represents a $1.22 annualized dividend and a dividend yield of 1.94%. Utah Medical Products’s dividend payout ratio (DPR) is presently 28.10%.

Analysts Set New Price Targets

Separately, StockNews.com downgraded shares of Utah Medical Products from a “strong-buy” rating to a “buy” rating in a research report on Thursday, November 7th.

Hedge Funds Weigh In On Utah Medical Products

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Martingale Asset Management L P raised its holdings in Utah Medical Products by 5.3% during the third quarter. Martingale Asset Management L P now owns 3,968 shares of the medical instruments supplier’s stock valued at $266,000 after acquiring an additional 201 shares during the period. Bard Associates Inc. lifted its holdings in Utah Medical Products by 1.1% in the 3rd quarter. Bard Associates Inc. now owns 19,781 shares of the medical instruments supplier’s stock worth $1,329,000 after purchasing an additional 224 shares in the last quarter. BNP Paribas Financial Markets boosted its stake in Utah Medical Products by 102.7% in the 3rd quarter. BNP Paribas Financial Markets now owns 1,117 shares of the medical instruments supplier’s stock worth $75,000 after purchasing an additional 566 shares during the period. State Street Corp grew its holdings in Utah Medical Products by 0.9% during the 3rd quarter. State Street Corp now owns 80,856 shares of the medical instruments supplier’s stock valued at $5,434,000 after buying an additional 694 shares in the last quarter. Finally, Copeland Capital Management LLC bought a new stake in shares of Utah Medical Products during the third quarter valued at approximately $53,000. Institutional investors own 69.60% of the company’s stock.

About Utah Medical Products

Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.